Hypertension caused by transgenic overexpression of Rac1

Hamdy H. Hassanain, David Gregg, Maria Luisa Marcelo, Jay L. Zweier, Heraldo P. Souza, Balakrishnan Selvakumar, Qi Ma, Moustafa Moustafa-Bayoumi, Phillip F. Binkley, Nicholas Flavahan, Mariana Morris, Chunming Dong, Pascal J. Goldschmidt-Clermont

Research output: Contribution to journalArticle

Abstract

Reactive oxygen species, including superoxide, are important mediators of the pathophysiology of hypertension. In the vasculature, superoxide antagonizes nitric oxide (NO), resulting in increased vascular tone. The GTP binding protein Rac regulates a wide variety of cellular functions, including the activation of NADPH oxidase, the major source of O 2 •- in the blood vessel wall. An hypothesis is that Rac1 may act as an important regulator of vascular O2 •- production, contributing to the balance between O 2 •- and NO and maintaining consequent homeostasis of blood pressure. To alter the activity of vascular NADPH oxidase, the authors developed a transgenic animal model that overexpresses the human cDNA of the constitutively active mutant of Rac1 (RacCA) in smooth muscle cells using the smooth muscle α-actin promoter. The RacCA transgenic had excessive amounts of O2 •- in the vessel wall that, which led to heightened production of peroxynitrite, as detected by increased protein nitration and reduced NO levels. RacCA mice developed moderate hypertension, which was corrected by N-acetyl-L-cysteine (NAC). RacCA transgenic mice also developed left ventricular hypertrophy as a secondary effect of pressure overload. The data suggest that Rac1 is a critical regulator of the redox state of blood vessels and homeostasis of blood pressure.

Original languageEnglish (US)
Pages (from-to)91-100
Number of pages10
JournalAntioxidants and Redox Signaling
Volume9
Issue number1
DOIs
StatePublished - Jan 2007
Externally publishedYes

Fingerprint

Blood Vessels
Nitric Oxide
NADPH Oxidase
Blood pressure
Blood vessels
Hypertension
Superoxides
Muscle
rac GTP-Binding Proteins
Nitration
Peroxynitrous Acid
Acetylcysteine
Homeostasis
Actins
Reactive Oxygen Species
Blood Pressure
Animals
Complementary DNA
Chemical activation
Cells

ASJC Scopus subject areas

  • Biochemistry

Cite this

Hassanain, H. H., Gregg, D., Marcelo, M. L., Zweier, J. L., Souza, H. P., Selvakumar, B., ... Goldschmidt-Clermont, P. J. (2007). Hypertension caused by transgenic overexpression of Rac1. Antioxidants and Redox Signaling, 9(1), 91-100. https://doi.org/10.1089/ars.2007.9.91

Hypertension caused by transgenic overexpression of Rac1. / Hassanain, Hamdy H.; Gregg, David; Marcelo, Maria Luisa; Zweier, Jay L.; Souza, Heraldo P.; Selvakumar, Balakrishnan; Ma, Qi; Moustafa-Bayoumi, Moustafa; Binkley, Phillip F.; Flavahan, Nicholas; Morris, Mariana; Dong, Chunming; Goldschmidt-Clermont, Pascal J.

In: Antioxidants and Redox Signaling, Vol. 9, No. 1, 01.2007, p. 91-100.

Research output: Contribution to journalArticle

Hassanain, HH, Gregg, D, Marcelo, ML, Zweier, JL, Souza, HP, Selvakumar, B, Ma, Q, Moustafa-Bayoumi, M, Binkley, PF, Flavahan, N, Morris, M, Dong, C & Goldschmidt-Clermont, PJ 2007, 'Hypertension caused by transgenic overexpression of Rac1', Antioxidants and Redox Signaling, vol. 9, no. 1, pp. 91-100. https://doi.org/10.1089/ars.2007.9.91
Hassanain HH, Gregg D, Marcelo ML, Zweier JL, Souza HP, Selvakumar B et al. Hypertension caused by transgenic overexpression of Rac1. Antioxidants and Redox Signaling. 2007 Jan;9(1):91-100. https://doi.org/10.1089/ars.2007.9.91
Hassanain, Hamdy H. ; Gregg, David ; Marcelo, Maria Luisa ; Zweier, Jay L. ; Souza, Heraldo P. ; Selvakumar, Balakrishnan ; Ma, Qi ; Moustafa-Bayoumi, Moustafa ; Binkley, Phillip F. ; Flavahan, Nicholas ; Morris, Mariana ; Dong, Chunming ; Goldschmidt-Clermont, Pascal J. / Hypertension caused by transgenic overexpression of Rac1. In: Antioxidants and Redox Signaling. 2007 ; Vol. 9, No. 1. pp. 91-100.
@article{0a51bd3eb4714f15b284a200264a62d6,
title = "Hypertension caused by transgenic overexpression of Rac1",
abstract = "Reactive oxygen species, including superoxide, are important mediators of the pathophysiology of hypertension. In the vasculature, superoxide antagonizes nitric oxide (NO•), resulting in increased vascular tone. The GTP binding protein Rac regulates a wide variety of cellular functions, including the activation of NADPH oxidase, the major source of O 2 •- in the blood vessel wall. An hypothesis is that Rac1 may act as an important regulator of vascular O2 •- production, contributing to the balance between O 2 •- and NO• and maintaining consequent homeostasis of blood pressure. To alter the activity of vascular NADPH oxidase, the authors developed a transgenic animal model that overexpresses the human cDNA of the constitutively active mutant of Rac1 (RacCA) in smooth muscle cells using the smooth muscle α-actin promoter. The RacCA transgenic had excessive amounts of O2 •- in the vessel wall that, which led to heightened production of peroxynitrite, as detected by increased protein nitration and reduced NO• levels. RacCA mice developed moderate hypertension, which was corrected by N-acetyl-L-cysteine (NAC). RacCA transgenic mice also developed left ventricular hypertrophy as a secondary effect of pressure overload. The data suggest that Rac1 is a critical regulator of the redox state of blood vessels and homeostasis of blood pressure.",
author = "Hassanain, {Hamdy H.} and David Gregg and Marcelo, {Maria Luisa} and Zweier, {Jay L.} and Souza, {Heraldo P.} and Balakrishnan Selvakumar and Qi Ma and Moustafa Moustafa-Bayoumi and Binkley, {Phillip F.} and Nicholas Flavahan and Mariana Morris and Chunming Dong and Goldschmidt-Clermont, {Pascal J.}",
year = "2007",
month = "1",
doi = "10.1089/ars.2007.9.91",
language = "English (US)",
volume = "9",
pages = "91--100",
journal = "Antioxidants and Redox Signaling",
issn = "1523-0864",
publisher = "Mary Ann Liebert Inc.",
number = "1",

}

TY - JOUR

T1 - Hypertension caused by transgenic overexpression of Rac1

AU - Hassanain, Hamdy H.

AU - Gregg, David

AU - Marcelo, Maria Luisa

AU - Zweier, Jay L.

AU - Souza, Heraldo P.

AU - Selvakumar, Balakrishnan

AU - Ma, Qi

AU - Moustafa-Bayoumi, Moustafa

AU - Binkley, Phillip F.

AU - Flavahan, Nicholas

AU - Morris, Mariana

AU - Dong, Chunming

AU - Goldschmidt-Clermont, Pascal J.

PY - 2007/1

Y1 - 2007/1

N2 - Reactive oxygen species, including superoxide, are important mediators of the pathophysiology of hypertension. In the vasculature, superoxide antagonizes nitric oxide (NO•), resulting in increased vascular tone. The GTP binding protein Rac regulates a wide variety of cellular functions, including the activation of NADPH oxidase, the major source of O 2 •- in the blood vessel wall. An hypothesis is that Rac1 may act as an important regulator of vascular O2 •- production, contributing to the balance between O 2 •- and NO• and maintaining consequent homeostasis of blood pressure. To alter the activity of vascular NADPH oxidase, the authors developed a transgenic animal model that overexpresses the human cDNA of the constitutively active mutant of Rac1 (RacCA) in smooth muscle cells using the smooth muscle α-actin promoter. The RacCA transgenic had excessive amounts of O2 •- in the vessel wall that, which led to heightened production of peroxynitrite, as detected by increased protein nitration and reduced NO• levels. RacCA mice developed moderate hypertension, which was corrected by N-acetyl-L-cysteine (NAC). RacCA transgenic mice also developed left ventricular hypertrophy as a secondary effect of pressure overload. The data suggest that Rac1 is a critical regulator of the redox state of blood vessels and homeostasis of blood pressure.

AB - Reactive oxygen species, including superoxide, are important mediators of the pathophysiology of hypertension. In the vasculature, superoxide antagonizes nitric oxide (NO•), resulting in increased vascular tone. The GTP binding protein Rac regulates a wide variety of cellular functions, including the activation of NADPH oxidase, the major source of O 2 •- in the blood vessel wall. An hypothesis is that Rac1 may act as an important regulator of vascular O2 •- production, contributing to the balance between O 2 •- and NO• and maintaining consequent homeostasis of blood pressure. To alter the activity of vascular NADPH oxidase, the authors developed a transgenic animal model that overexpresses the human cDNA of the constitutively active mutant of Rac1 (RacCA) in smooth muscle cells using the smooth muscle α-actin promoter. The RacCA transgenic had excessive amounts of O2 •- in the vessel wall that, which led to heightened production of peroxynitrite, as detected by increased protein nitration and reduced NO• levels. RacCA mice developed moderate hypertension, which was corrected by N-acetyl-L-cysteine (NAC). RacCA transgenic mice also developed left ventricular hypertrophy as a secondary effect of pressure overload. The data suggest that Rac1 is a critical regulator of the redox state of blood vessels and homeostasis of blood pressure.

UR - http://www.scopus.com/inward/record.url?scp=33845457599&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=33845457599&partnerID=8YFLogxK

U2 - 10.1089/ars.2007.9.91

DO - 10.1089/ars.2007.9.91

M3 - Article

C2 - 17115888

AN - SCOPUS:33845457599

VL - 9

SP - 91

EP - 100

JO - Antioxidants and Redox Signaling

JF - Antioxidants and Redox Signaling

SN - 1523-0864

IS - 1

ER -